2018
DOI: 10.1177/0269215518791658
|View full text |Cite
|
Sign up to set email alerts
|

Effect of adding neuromuscular electrical stimulation training to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: randomized clinical trial

Abstract: The neuromuscular electrical stimulation added to pulmonary rehabilitation group benefited from better walking tolerance and greater balance improvement than the only pulmonary rehabilitation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
35
0
4

Year Published

2020
2020
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(39 citation statements)
references
References 46 publications
(57 reference statements)
0
35
0
4
Order By: Relevance
“…Our search identified 76 unique studies, of which 15 fulfilled eligibility criteria. 11,12,[18][19][20][21][22][23][24][25][26][27][28][29][30] Reasons for exclusion were no balance or fall risk outcome reported (n = 3), not describing original data (n = 1), results from patients with COPD were not specified (n = 2), not meeting the mini-mum intervention duration of 14 d (n = 1), and no RCT or a within-group study design (n = 1) (see Supplemental Digital Content 2, available at: http://links.lww.com/JCRP/ A174).…”
Section: Study Selectionmentioning
confidence: 99%
“…Our search identified 76 unique studies, of which 15 fulfilled eligibility criteria. 11,12,[18][19][20][21][22][23][24][25][26][27][28][29][30] Reasons for exclusion were no balance or fall risk outcome reported (n = 3), not describing original data (n = 1), results from patients with COPD were not specified (n = 2), not meeting the mini-mum intervention duration of 14 d (n = 1), and no RCT or a within-group study design (n = 1) (see Supplemental Digital Content 2, available at: http://links.lww.com/JCRP/ A174).…”
Section: Study Selectionmentioning
confidence: 99%
“…Die Charakteristika der eingeschlossenen Studien sind in Tabelle 2, Tabelle 3 und Tabelle 4 dargestellt. Von den 42 eingeschlossenen Studien schlossen 32 Patienten mit COPD ein [33, 37, 42-44, 48, 49, 53-55, 57, 59, 68, 80, 85, 90, 101, 104, 106-108, 120, 121, 123, 124, 128, 129, 136, 146, 147, 151, 167], 2 Studien schlossen Patienten mit Asthma ein [186, 189] und 8 Studien schlossen Patienten mit ILD ein [196, 198, 201-203, 207-209]. Bei den meisten Studien handelte es sich um randomisierte kontrollierte Studien (n = 24; 57,1%) [37, 43, 44, 49, 53, 80, 85, 120, 121, 123, 124, 129, 146, 147, 151, 167, 186, 189, 196, 198, 202, 207-209].…”
Section: Ergebnisseunclassified
“…Neunzehn Studien mit COPD-Patienten [37, 49, 53, 57, 80, 90, 104, 106-108, 120, 121, 123, 124, 128, 129, 136, 146, 147], 2 Studien mit Asthma-Patienten [186, 189] und 5 Studien mit ILD-Patienten [196, 201, 202, 207, 209] enthielten Angaben zu kardiovaskulären Outcomes und Outcome-Maßen. In Studien mit COPD-Patienten fand sich eine Vielzahl von Outcome-Maßen, wohingegen Studien mit Asthma-Patienten hauptsächlich auf das Serumlipidprofil ausgerichtet waren [187, 190] (n = 2), und in Studien mit ILD-Patienten vornehmlich die Herzfrequenz in Ruhe [196, 201, 209] (n = 3) und der Blutdruck [196, 207, 209] (n = 3) berichtet wurden.…”
Section: Ergebnisseunclassified
See 2 more Smart Citations